SE464615B - Fast farmaceutisk komposition med foerbaettrad stabilitet innehaallande ett eller flera beta-laktamantibiotika - Google Patents

Fast farmaceutisk komposition med foerbaettrad stabilitet innehaallande ett eller flera beta-laktamantibiotika

Info

Publication number
SE464615B
SE464615B SE8304857A SE8304857A SE464615B SE 464615 B SE464615 B SE 464615B SE 8304857 A SE8304857 A SE 8304857A SE 8304857 A SE8304857 A SE 8304857A SE 464615 B SE464615 B SE 464615B
Authority
SE
Sweden
Prior art keywords
carbon dioxide
composition according
base
sodium carbonate
antibiotic
Prior art date
Application number
SE8304857A
Other languages
English (en)
Swedish (sv)
Other versions
SE8304857L (sv
SE8304857D0 (sv
Inventor
B L Richardson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8304857D0 publication Critical patent/SE8304857D0/xx
Publication of SE8304857L publication Critical patent/SE8304857L/xx
Publication of SE464615B publication Critical patent/SE464615B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
SE8304857A 1982-09-10 1983-09-09 Fast farmaceutisk komposition med foerbaettrad stabilitet innehaallande ett eller flera beta-laktamantibiotika SE464615B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8225853 1982-09-10

Publications (3)

Publication Number Publication Date
SE8304857D0 SE8304857D0 (sv) 1983-09-09
SE8304857L SE8304857L (sv) 1984-03-11
SE464615B true SE464615B (sv) 1991-05-27

Family

ID=10532830

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304857A SE464615B (sv) 1982-09-10 1983-09-09 Fast farmaceutisk komposition med foerbaettrad stabilitet innehaallande ett eller flera beta-laktamantibiotika

Country Status (20)

Country Link
US (2) US4582830A (da)
JP (1) JPS5973518A (da)
KR (1) KR880001094B1 (da)
AT (1) AT388671B (da)
AU (1) AU566245B2 (da)
BE (1) BE897721A (da)
CA (1) CA1215647A (da)
CH (1) CH655008A5 (da)
DE (1) DE3332616C2 (da)
DK (1) DK161304C (da)
ES (1) ES8502863A1 (da)
FR (1) FR2532849B1 (da)
GB (1) GB2126479B (da)
IE (1) IE55720B1 (da)
IT (1) IT1197708B (da)
NL (1) NL189948C (da)
NZ (1) NZ205539A (da)
PT (1) PT77323B (da)
SE (1) SE464615B (da)
ZA (1) ZA836703B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
AT393452B (de) * 1985-08-05 1991-10-25 Bristol Myers Squibb Co Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung
JPH02500591A (ja) * 1987-05-27 1990-03-01 アクゾ・エヌ・ヴエー β‐ラクタム抗生物質の乾燥した急速溶解性の組成物
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
WO1996017578A1 (en) * 1994-12-08 1996-06-13 Otsuka Pharmaceutical Factory, Inc. Method of suppressing adsorption of substances derived from container material on drugs and container
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
CA2239331C (en) * 1998-05-29 1999-11-30 Bernard Charles Sherman Pharmaceutical tablets comprising cefuroxime axetil
WO2004096279A1 (ja) 2003-04-28 2004-11-11 Takeda Pharmaceutical Company Limited 注射用組成物
JP4700291B2 (ja) * 2003-04-28 2011-06-15 武田薬品工業株式会社 注射用組成物
EP1625859A1 (en) * 2004-08-13 2006-02-15 Access Group ApS A process for the preparation of a package comprising a sterilised bulk of a substance, and a package comprising a sterilised bulk of a penicilin
CN102920710B (zh) * 2012-11-16 2014-05-28 罗诚 一种头孢地嗪化合物的药物组合物
CN103432137B (zh) * 2013-08-28 2015-01-28 芦红代 头孢西丁的药物组合物
CN113350511B (zh) * 2021-03-01 2024-01-02 郎俊娜 一种新型注射用无菌粉末灌装混合保护气
CN116588404A (zh) * 2022-12-31 2023-08-15 浙江惠迪森药业有限公司 注射用无菌粉末灌装保护气制作方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB760087A (en) * 1952-10-16 1956-10-31 Novo Terapeutisk Labor As Process of increasing the physical stability of aqueous suspensions of penicillin compounds
GB737242A (en) * 1952-10-16 1955-09-21 Novo Terapeutisk Labor As Process of increasing the physical stability of aqueous suspensions of penicillin compounds
GB1132583A (en) * 1964-12-16 1968-11-06 Glaxo Lab Ltd Pharmaceutical compositions containing cephalosporins
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions
AT307616B (de) * 1969-05-02 1973-05-25 Biochemie Gmbh Verfahren zur Herstellung einer Brausezubereitung
GB1380741A (en) * 1971-02-05 1975-01-15 Squibb & Sons Inc Antibiotic compositions and their preparation
US3940483A (en) * 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method
LU65921A1 (da) * 1972-08-18 1974-02-21
US4160829A (en) * 1972-12-22 1979-07-10 Gist-Brocades N.V. Antibacterial 1,2,4-oxadiazolylacetamido cephalosporins
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
DE2461969A1 (de) * 1974-12-31 1976-07-08 Behringwerke Ag Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen
CA1051780A (en) * 1975-04-09 1979-04-03 Bahram Farhadieh Stable chelocardin composition
GB1575905A (en) * 1976-04-28 1980-10-01 Glaxo Lab Ltd Salt of cefuroxime
GB1504767A (en) * 1976-08-23 1978-03-22 Beecham Group Ltd Antibiotic compositions
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
DK447878A (da) * 1977-10-10 1979-04-11 Glaxo Group Ltd Beta-laktamforbindelser og fremgangsmaade til fremstilling deraf
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions
FR2445833A1 (fr) * 1979-01-04 1980-08-01 Chimie Biolog Nouveaux sels d'antibiotiques amines a cycle beta lactame
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic

Also Published As

Publication number Publication date
SE8304857L (sv) 1984-03-11
NL189948C (nl) 1993-09-16
NL8303125A (nl) 1984-04-02
AT388671B (de) 1989-08-10
DK161304B (da) 1991-06-24
DK409183A (da) 1984-03-11
FR2532849A1 (fr) 1984-03-16
FR2532849B1 (fr) 1986-08-22
KR840006126A (ko) 1984-11-22
NL189948B (nl) 1993-04-16
IT8348950A1 (it) 1985-03-09
PT77323A (en) 1983-10-01
IE55720B1 (en) 1991-01-02
IT8348950A0 (it) 1983-09-09
DK409183D0 (da) 1983-09-09
GB8324133D0 (en) 1983-10-12
PT77323B (en) 1986-02-06
BE897721A (fr) 1984-03-09
AU566245B2 (en) 1987-10-15
DE3332616A1 (de) 1984-03-15
ZA836703B (en) 1984-10-31
DE3332616C2 (de) 1995-06-01
IT1197708B (it) 1988-12-06
US4803196A (en) 1989-02-07
GB2126479B (en) 1986-04-03
ES525492A0 (es) 1985-02-01
ATA322783A (de) 1989-01-15
CA1215647A (en) 1986-12-23
ES8502863A1 (es) 1985-02-01
JPS5973518A (ja) 1984-04-25
IE832118L (en) 1984-03-10
NZ205539A (en) 1986-03-14
CH655008A5 (de) 1986-03-27
KR880001094B1 (ko) 1988-06-29
SE8304857D0 (sv) 1983-09-09
US4582830A (en) 1986-04-15
GB2126479A (en) 1984-03-28
DK161304C (da) 1991-12-02
AU1897583A (en) 1984-03-15
JPH0480883B2 (da) 1992-12-21

Similar Documents

Publication Publication Date Title
SE464615B (sv) Fast farmaceutisk komposition med foerbaettrad stabilitet innehaallande ett eller flera beta-laktamantibiotika
CN1095670C (zh) 含碳酸氢盐的粉状药用组合物的包装及稳定该组合物的方法
CA1056729A (en) Injectable amoxycillin composition
EP1142573A1 (en) Antibacterial medicinal compositions
JPH10500975A (ja) 乾燥剤を含有する注射用製剤
JP4854899B2 (ja) カルバペネム系抗生物質組成物の処方方法
CN113350511A (zh) 一种新型注射用无菌粉末灌装混合保护气
KR19980075408A (ko) β-락탐 항생물질을 함유하는 약학 조성물의 안정화 방법
EP0052962B1 (en) Pharmaceutical compositions containing two beta-lactam derivatives
EP0029668B1 (en) Pharmaceutical injectable composition and two-pack container for said composition
JP2761005B2 (ja) セファロスポリン含有注射用組成物
EP0008905B1 (en) Pharmaceutical compositions containing two beta-lactam derivatives
EP0008525A2 (en) Pharmaceutical compositions and process for their preparation
GB2087721A (en) Injectable antibiotic formulations stabilised with glycofurol
EP0843552A2 (en) Pharmaceutical formulations
KR100396464B1 (ko) 세푸록심의 나트륨염을 함유하는 약학적 조성물의 안정화방법
JPH02279627A (ja) 抗菌組成物
GB2167302A (en) Stable lyophilized antibacterial preparations
KR19990001504A (ko) 세프타지딤의 유기알카리염을 함유하는 주사제
JPS63307824A (ja) 安定化注射用粉末製剤
JPH053848B2 (da)
JPH06100452A (ja) イホスファミド用の製薬学的容器

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8304857-9

Format of ref document f/p: F

NUG Patent has lapsed